Evidence map›Paper›PMID 32556920›Full record

ArticleInternational journal of computer assisted radiology and surgery2020

Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.

Mohammed El Adoui, Stylianos Drisis, Mohammed Benjelloun

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of computer assisted radiology and surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. [Artificial intelligence in predicting pathological complete response to neoadjuvant chemotherapy for breast cancer: current advances and challenges].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammed El AdouiComputer Science Unit, Faculty of Engineering, University of Mons, Mons, Belgium. Mohammed.Eladoui@umons.ac.be.ORCID http://orcid.org/0000-0003-1891-2318
Stylianos DrisisJules Bordet Institute, Brussels, Belgium.ORCID http://orcid.org/0000-0001-8936-1598
Mohammed BenjellounComputer Science Unit, Faculty of Engineering, University of Mons, Mons, Belgium.ORCID http://orcid.org/0000-0002-4020-7327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNeoadjuvant chemotherapy (NAC) aims to minimize the tumor size before surgery. Predicting response to NAC could reduce toxicity and delays to effective intervention. Computational analysis of dynamic contrast-enhanced magnetic resonance images (DCE-MRI) through deep convolution neural network (CNN) has shown a significant performance to distinguish responders and no responder's patients. This study intends to present a new deep learning (DL) model predicting the breast cancer response to NAC based on multiple MRI inputs.

methodsA cohort of 723 axial slices extracted from 42 breast cancer patients who underwent NAC therapy was used to train and validate the developed DL model. This dataset was provided by our collaborator institute of radiology in Brussels. Fourteen external cases were used to validate the best obtained model to predict pCR based on pre- and post-chemotherapy DCE-MRI. The model performance was assessed by area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, and feature map visualization.

resultsThe developed multi-inputs deep learning architecture was able to predict the pCR to NAC treatment in the validation dataset with an AUC of 0.91 using combined pre- and post-NAC images. The visual results showed that the most important extracted features from non-pCR tumors are in the peripheral region. The proposed method was more productive than the previous ones.

conclusionEven with a limited training dataset size, the proposed and developed CNN model using DCE-MR images acquired before and after the first chemotherapy was able to classify pCR and non-pCR patients with substantial accuracy. This model could be used hereafter in clinical analysis after its evaluation based on more extra data.

Indexed as

Deep LearningMagnetic Resonance ImagingNeoadjuvant TherapyAdultAntineoplastic AgentsArea Under CurveBreast NeoplasmsChemotherapy, AdjuvantContrast MediaDiagnosis, Computer-AssistedFemaleHumansImage Processing, Computer-AssistedMiddle AgedNeural Networks, ComputerRetrospective StudiesAntineoplastic AgentsContrast MediaBreast cancerCNNDCE-MRIDeep learningFeatures visualizationMulti-input network

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.